Gabapentin

Product NDC: 71335-2741
11-digit product format: 713352741
Labeler code: 71335
Product ID: 71335-2741_cd9f3596-223b-483c-9951-2beee373bde2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Gabapentin
Dosage form: CAPSULE
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA206943
Marketing category: ANDA
Marketing start: 2018-05-14
Substance: GABAPENTIN
Active strength: 100 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

openFDA Listing Details

Product ID: 71335-2741_cd9f3596-223b-483c-9951-2beee373bde2
SPL ID: cd9f3596-223b-483c-9951-2beee373bde2
Product type: HUMAN PRESCRIPTION DRUG
Finished product: Yes
Brand name base: Gabapentin
Generic name: Gabapentin
Dosage form: CAPSULE
Route: ORAL
Marketing start: 2018-05-14
Marketing category: ANDA
Application number: ANDA206943
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
Listing expiration: 2026-12-31

Ingredient	Strength
GABAPENTIN	100 mg/1

Package NDC	Description	Marketing start	Sample
71335-2741-1	90 CAPSULE in 1 BOTTLE (71335-2741-1)	2025-07-28	No

UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
71335-2741-1	71335274101	90 CAPSULE in 1 BOTTLE (71335-2741-1)	90 capsule	2025-07-28	No	No	Historical

Title	Manufacturer	Effective date	Type	Version
Gabapentin	Bryant Ranch Prepack	2025-07-28	HUMAN PRESCRIPTION DRUG LABEL	100